Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5%, a generic equivalent to Lotemax, for eye inflammation treatment.

Lupin today announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States. Loteprednol Etabonate Ophthalmic Suspension, 0.5% is bioequivalent to Lotemax Ophthalmic ...

Mumbai: Global pharma major Lupin Limited has launched Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United ...

Lupin launches generic Loteprednol Etabonate Ophthalmic Suspension in the US market, a bioequivalent to Lotemax, to treat eye ...

Lupin has launched a generic eye medication in the US, aimed at treating inflammation and pain. This new product is a generic ...

Lupin introduces loteprednol etabonate ophthalmic suspension, 0.5% in US: Our Bureau, Mumbai Wednesday, July 16, 2025, 16:20 Hrs [IST] Global pharma major Lupin Limited (Lupin) an ...

Lupin announced that it has launched Loteprednol Etabonate Ophthalmic Suspension in the United States.

Loteprednol etabonate ophthalmic gel, 0.38%, is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery.

According to IQVIA MAT data for May 2025, Loteprednol Etabonate Ophthalmic Gel, 0.38% (Reference Listed Drug: Lotemax (R) SM) had estimated annual sales of $29 million in the U.S.

This is eligible for 180 days of generic drug exclusivity. The company will manufacture the product at its facility situated in India.

Heads of State and Government gather for a group photo at the recent Africa Energy Summit in Dar es Salaam, Tanzania. EVERYDAY, the simple act of cooking becomes a silent killer for millions of ...

This Instant 4000 Lotemax review will study the trading platform’s main aspects to see if it’s worth trying out or not.